...
首页> 外文期刊>Archives of Pharmacal Research >Phentolamine inhibits the pacemaker activity of mouse interstitial cells of Cajal by activating ATP-sensitive K+ channels
【24h】

Phentolamine inhibits the pacemaker activity of mouse interstitial cells of Cajal by activating ATP-sensitive K+ channels

机译:酚妥拉明通过激活ATP敏感的K + 通道来抑制Cajal小鼠间质细胞的起搏器活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to clarify if phentolamine has proven effects on the pacemaker activities of interstitial cells of Cajal (ICC) from the mouse small intestine involving the ATPsensitive K+ channels and adrenergic receptor. The actions of phentolamine on pacemaker activities were investigated using whole-cell patch-clamp technique and intracellular Ca2+ analysis at 30°C in cultured mouse intestinal ICC. ICC generated spontaneous pacemaker currents at a holding potential of −70 mV. Treatment with phentolamine reduced the frequency and amplitude of the pacemaker currents and increased the resting outward currents. Moreover, under current clamping (I = 0), phentolamine hyperpolarized the ICC membrane and decreased the amplitude of the pacemaker potentials. We also observed that phentolamine inhibited spontaneous [Ca2+]i oscillations in ICC. The alpha-adrenergic drugs prazosin, yohimbine, methoxamine, and clonidine had no effect on ICC intestinal pacemaker activity and did not block phentolamine-induced effects. Phentolamine-induced effects on the pacemaker currents and the pacemaker potentials were significantly inhibited by ATP sensitive K+ channel blocker glibenclamide, but not by TEA, apamin, or 4-aminopyridine. In addition, the NO synthase inhibitor, L-NAME and the guanylate cyclase inhibitor, ODQ were incapable of blocking the phentolamine-induced effects. These results demonstrate that phentolamine regulates the pacemaker activity of ICC via ATP-sensitive K+ channel activation. Phentolamine could act through an adrenergic receptor- and also through NO-independent mechanism that involves intracellular Ca2+ signaling.
机译:这项研究的目的是阐明苯妥拉明是否对小鼠小肠中涉及ATP敏感的K + 通道和肾上腺素能受体的Cajal(ICC)间质细胞的起搏器活性具有有效的作用。采用全细胞膜片钳技术,在30℃培养的小鼠肠道ICC中,通过细胞内Ca 2 + 分析研究酚妥拉明对起搏器活性的作用。 ICC产生自发性起搏器电流,保持电位为-70 mV。用酚妥拉明治疗可降低起搏器电流的频率和幅度,并增加静息的向外电流。此外,在电流钳制(I = 0)下,酚妥拉明使ICC膜超极化,并降低了起搏器电位的幅度。我们还观察到酚妥拉明抑制了ICC中的自发[Ca 2 + ] i 振荡。 α-肾上腺素药物哌唑嗪,育亨宾,甲氧明和可乐定对ICC肠起搏器活性没有影响,也没有阻断苯妥拉明诱导的作用。 ATP敏感的K + 通道阻滞剂格列本脲明显抑制苯酚胺对起搏器电流和起搏器电位的影响,而对TEA,木瓜蛋白酶或4-氨基吡啶则无明显作用。此外,NO合酶抑制剂L-NAME和鸟苷酸环化酶抑制剂ODQ无法阻止酚妥拉明诱导的作用。这些结果表明,酚妥拉明通过ATP敏感的K + 通道激活调节ICC的起搏器活性。酚妥拉明可能通过肾上腺素能受体起作用,也可以通过不依赖NO的机制参与细胞内Ca 2 + 信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号